Clinical Trial Update: Detection of Early Esophageal Cancer by NIR-FME. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating detection of early esophageal cancer in Barrett Esophagus using near-infrared fluorescence molecular endoscopy (NIR-FME).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Barrett Esophagus | Phase 2 | Status: UNKNOWN